J Clin Transl Res 2021 Apr 16;7(2):185-198. Epub 2021 Apr 16.
Department of Radiation Oncology, Hospital Universitario Quirónsalud Madrid, C/Diego de Velázquez, 1, 28223, Pozuelo de Alarcón, Madrid, Spain.
Background And Aim: In Stage IIIA-N2 non-small cell lung cancer (NSCLC), the accuracy of combined positron-emission tomography/computed tomography imaging (PET-CT), together with mediastinal staging techniques, has led to a wide range of challenging clinical scenarios in terms of therapeutic management. Concurrent chemoradiotherapy followed by consolidation immunotherapy remains the standard of care. In patients with potentially-resectable disease, surgery plays an important role in multimodal therapy. Read More